G. St‐Germain

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

Ana Espinel‐Ingroff, Ana Isabel Aller, Laura Rosío Castañón-Olivares et al. · Antimicrobial Agents and Chemotherapy · 2012 · 246 citations · Full text

Diagnostic Mycology, Pathogenic Microbiology, Pathogen Detection +17

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

Ana Espinel‐Ingroff, Maiken Cavling Arendrup, Michael A. Pfaller et al. · Antimicrobial Agents and Chemotherapy · 2013 · 204 citations · Full text

Diagnostic Mycology, Candida Spp, Clinical Mycology +18

Prevalence and Antifungal Susceptibility of 442 <i>Candida</i> Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, Canada

G. St‐Germain, Michél Laverdière, René Pelletier et al. · Journal of Clinical Microbiology · 2001 · 132 citations · Full text

Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole

Ana Espinel‐Ingroff, Michael A. Pfaller, Beatriz Bustamante et al. · Antimicrobial Agents and Chemotherapy · 2014 · 103 citations · Full text

Diagnostic Mycology, Clinical Mycology, Mic Data +16

AIDS Patient Death Caused by Novel<i>Cryptococcus neoformans</i>×<i>C</i>.<i>gattii</i>Hybrid

Marjan Bovers, Ferry Hagen, Eiko E. Kuramae et al. · Emerging infectious diseases · 2008 · 98 citations · Full text